February 13, 2025

Dopamine D1 Receptors

Moreover, useful in vivo imaging may require several, preferably combined, and advanced imaging modalities to examine different but complementary characteristics of molecules, cells, or tissues
3 min read

Moreover, useful in vivo imaging may require several, preferably combined, and advanced imaging modalities to examine different but complementary characteristics of molecules, cells, or tissues

cmerp September 23, 2024
Moreover, useful in vivo imaging may require several, preferably combined, and advanced imaging modalities to examine different...
Read More
Inside our study, 66 patients had autoantibody positivity in support of 35 patients had serological proof both anti-tTG and anti-EMA positivity and had discrepant findings
3 min read

Inside our study, 66 patients had autoantibody positivity in support of 35 patients had serological proof both anti-tTG and anti-EMA positivity and had discrepant findings

cmerp April 30, 2023
Inside our study, 66 patients had autoantibody positivity in support of 35 patients had serological proof both...
Read More
Erlotinib and afatinib (from the Organic Synthesis Core Facility at MSKCC), osimertinib (AstraZeneca) and dacomitinib (Selleck) were dissolved in DMSO
3 min read

Erlotinib and afatinib (from the Organic Synthesis Core Facility at MSKCC), osimertinib (AstraZeneca) and dacomitinib (Selleck) were dissolved in DMSO

cmerp January 28, 2023
Erlotinib and afatinib (from the Organic Synthesis Core Facility at MSKCC), osimertinib (AstraZeneca) and dacomitinib (Selleck) were...
Read More

You may have missed

Negative controls utilized were either PBS only or an IgM isotype control (clone MM-30) at the best dose (200 g)
3 min read

Negative controls utilized were either PBS only or an IgM isotype control (clone MM-30) at the best dose (200 g)

February 3, 2025
A cell-based assay detected the individual was positive for anti-MOG antibodies (1:512) and adverse for anti-AQP4 in serum
4 min read

A cell-based assay detected the individual was positive for anti-MOG antibodies (1:512) and adverse for anti-AQP4 in serum

February 2, 2025
Dosages were gradated in logarithmic techniques symmetrically and downwards from the fifty percent effective dosage determined in Fig upwards
4 min read

Dosages were gradated in logarithmic techniques symmetrically and downwards from the fifty percent effective dosage determined in Fig upwards

January 31, 2025
Cut\off value for IgG4/IgG ratio, 275%; sensitivity, 075; specificity, 074; AUC, 080; 95% CI for the AUC, 066C094
2 min read

Cut\off value for IgG4/IgG ratio, 275%; sensitivity, 075; specificity, 074; AUC, 080; 95% CI for the AUC, 066C094

January 30, 2025